The Implications of the BRCA Gene Patent Rulings for Individualized Medicine

Mark A. Nelson

doi:10.4172/2161-0681.1000e101

ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial
J Clinic Experiment Pathol 2011, Vol 1(1): e101
DOI: 10.4172/2161-0681.1000e101

The Implications of the BRCA Gene Patent Rulings for Individualized Medicine

Mark A. Nelson^*: Professor of Pathology, University of Arizona, USA

^*Corresponding Author : Mark A. Nelson, Ph. D. Professor of Pathology, University of Arizona1501 N. Campbell AvenueTucson, Arizona, USA, Tel: 520 626 2619, Fax: 520 626 1027, Email: mnelson@azcc.arizona.edu

Received Date: Aug 11, 2011 / Accepted Date: Sep 05, 2011 / Published Date: Nov 12, 2011

View PDF Download PDF

Citation: Nelson MA (2011) The Implications of the BRCA Gene Patent Rulings for Individualized Medicine. J Clinic Experiment Pathol 1:e101. Doi: 10.4172/2161-0681.1000e101

Copyright: © 2011 Nelson MA. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.